If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
777.50    -5.00 (-0.64%)
Bid:
779.50
Ask:
782.00
Spread: 2.50 (0.321%)
Market Cap: £896.42m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Update

12 Apr 2017 07:00

RNS Number : 2464C
Kainos Group plc
12 April 2017
 

12 April 2017

 

Kainos Group plc

 

("Kainos" or "the Company")

 

Trading Update

 

Kainos Group plc, a leading provider of Digital Services and Platforms, today issues a trading update for the year ended 31 March 2017.

 

Trading in the year ended 31 March 2017 has continued to be in line with market expectations; the Company has experienced good growth across all divisions, and remains well positioned in its core markets.

 

The increasing trends towards digitisation and adoption of enterprise Software as a Service (SaaS) solutions have continued to generate strong demand for the Company's Digital Services in both public and commercial markets in the UK and Europe.

 

Growth in Digital Platforms remains solid, supported by sustained momentum of Kainos WorkSmart contract wins, although limited funding in the UK's NHS continues to moderate short term growth of Kainos Evolve platforms. The Company continues to invest in development, sales and marketing of its Evolve Integrated Care platform.

 

Kainos has a robust balance sheet with no debt and strong cash generation. The business has a solid pipeline, which includes a growing level of recurring revenue. Recruitment remains strong, with over 216 people joining Kainos since 1 April 2016, bringing the total number of employees and contractors worldwide to 975 at the end of March 2017.

 

The announcement of Kainos results for the year ended 31 March 2017 will be made on Tuesday 30 May 2017.

 

- ENDS -

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Brian Gannon, SVP Corporate Development

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Dominic Emery

 

Canaccord Genuity +44 20 7523 4606

Simon Bridges / Emma Gabriel

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Nicola Krafft

 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the largest boutique partner for Workday Inc. ('Workday') in Europe, responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Kainos employs approximately 1,000 staff and contractors across eight offices in Europe and the USA, working interchangeably across its Services and Platforms businesses.

Kainos is listed on the London Stock Exchange (KNOS). For further information, please visit www.kainos.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTIBMFTMBMBBJR
Date   Source Headline
31st Dec 202110:26 amRNSTotal Voting Rights
13th Dec 20213:26 pmRNSDirector/PDMR Shareholding
2nd Dec 20213:23 pmRNSTotal Voting Rights
24th Nov 20211:11 pmRNSPerson Closely Associated shareholdings
18th Nov 20213:34 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSKainos Half-year Report
1st Nov 20215:15 pmRNSTotal Voting Rights
1st Oct 202110:28 amRNSTotal Voting Rights
29th Sep 20213:33 pmRNSHolding(s) in Company
29th Sep 20211:18 pmRNSDirector/PDMR Shareholding
23rd Sep 20215:33 pmRNSAGM Results
23rd Sep 20215:30 pmRNSDirectorate Change
8th Sep 20213:15 pmRNSDirector/PDMR Shareholding
2nd Sep 202110:20 amRNSDirector/PDMR Shareholding
1st Sep 20215:38 pmRNSTotal Voting Rights
1st Sep 20217:00 amRNSTrading Statement
1st Sep 20217:00 amRNSAcquisition
25th Aug 20212:28 pmRNSDirector/PDMR Shareholding
18th Aug 202111:28 amRNSNotice of AGM
12th Aug 20212:05 pmRNSDirector/PDMR Shareholding
10th Aug 202112:41 pmRNSChange of Auditor
2nd Aug 202111:57 amRNSTotal Voting Rights
30th Jul 202112:25 pmRNSAnnual Financial Report
9th Jul 20216:31 pmRNSDirector/PDMR Shareholding
1st Jul 20214:35 pmRNSTotal Voting Rights
29th Jun 20213:58 pmRNSDirector/PDMR Shareholding
1st Jun 20217:00 amRNSAcquisition
24th May 20217:00 amRNSKainos Final Results
21st May 20217:00 amRNSBoard Changes
4th May 202111:49 amRNSTotal Voting Rights
16th Apr 20217:00 amRNSKainos Trading Statement
8th Apr 20213:51 pmRNSHolding(s) in Company
7th Apr 20214:02 pmRNSHolding(s) in Company
1st Apr 20214:23 pmRNSTotal Voting Rights
31st Mar 20214:14 pmRNSHolding(s) in Company
29th Mar 20214:16 pmRNSHolding(s) in Company
23rd Mar 20214:42 pmRNSHolding(s) in Company
11th Mar 20213:50 pmRNSHolding(s) in Company
1st Mar 202111:14 amRNSTotal Voting Rights
18th Feb 20214:26 pmRNSHolding(s) in Company
11th Feb 20213:28 pmRNSHolding(s) in Company
11th Feb 20212:12 pmRNSDirector/PDMR Shareholding
10th Feb 20215:00 pmRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSKainos Trading Update
31st Dec 202010:00 amRNSTotal Voting Rights
21st Dec 20207:00 amRNSKainos Appoint Independent Non-Executive Director
17th Dec 20204:05 pmRNSHolding(s) in Company
16th Dec 20206:06 pmRNSHolding(s) in Company
3rd Dec 20204:49 pmRNSDirector/PDMR Shareholding
1st Dec 20208:16 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.